Price$80.00-10.45 (-11.56%)
2026-03-042026-06-05
News · 26 weeks39-60%
2025-12-142026-06-07
Mix1190d
- SEC Filings6(55%)
- Other3(27%)
- Earnings2(18%)
Latest news
25 items- SECGlobus Medical Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - GLOBUS MEDICAL INC (0001237831) (Filer)
- SECSEC Form SD filed by Globus Medical Inc.SD - GLOBUS MEDICAL INC (0001237831) (Filer)
- SECSEC Form 10-Q filed by Globus Medical Inc.10-Q - GLOBUS MEDICAL INC (0001237831) (Filer)
- SECGlobus Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - GLOBUS MEDICAL INC (0001237831) (Filer)
- PRGlobus Medical Reports First Quarter 2026 ResultsAUDUBON, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, today announced its financial results for the first quarter ended March 31, 2026. First Quarter 2026: Worldwide net sales were $759.9 million, an increase of 27.0%, or an increase of 25.5% on a constant currency basis.Base business, excluding Nevro, net sales were $677.2 million, an increase of 13.2%, or an increase of 11.2% on a constant currency basis.GAAP net income for the quarter was $124.3 million.GAAP diluted earnings per share ("EPS") was $0.90, an increase of 66.6%. Non-GAAP diluted EPS was $1.12, an increase of 64.7%. "We're off to a strong start in 20
- SECSEC Form DEFA14A filed by Globus Medical Inc.DEFA14A - GLOBUS MEDICAL INC (0001237831) (Filer)
- SECSEC Form DEF 14A filed by Globus Medical Inc.DEF 14A - GLOBUS MEDICAL INC (0001237831) (Filer)
- PRGlobus Medical Schedules First Quarter Earnings Release and Conference CallAUDUBON, Pa., April 16, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March 31, 2026 after the market close on Thursday, May 7, 2026. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com. Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Participants may access the conference call live via webcast on the Investors page of Globus Medical's website at https://www.investors.globusmedical.com/news-events/events-webcast
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Globus Medical Inc.SCHEDULE 13G/A - GLOBUS MEDICAL INC (0001237831) (Subject)
- SECGlobus Medical Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - GLOBUS MEDICAL INC (0001237831) (Filer)
- PRGlobus Medical Announces Board DepartureAUDUBON, Pa., March 23, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that John A. DeFord, PhD, a Director of Globus Medical Inc., notified the company of his decision to step down from the Board of Directors effective immediately and will not seek re-election at the Annual Meeting of Stockholders on June 3, 2026. "We are grateful for John's many contributions, especially during the merger with NuVasive and his service on the Nominating and Governance Committee. While we will miss his insights and expertise, we wish him continued success in his future endeavors," said David C. Paul, Chairman of the Board. "It has b
- INSIDEREVP, GC, Corporate Secretary Huller Kelly exercised 20,000 shares at a strike of $43.58 and sold $1,890,000 worth of shares (20,000 units at $94.50) (SEC Form 4)4 - GLOBUS MEDICAL INC (0001237831) (Issuer)
- SECSEC Form 10-K filed by Globus Medical Inc.10-K - GLOBUS MEDICAL INC (0001237831) (Filer)
- SECGlobus Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - GLOBUS MEDICAL INC (0001237831) (Filer)
- PRGlobus Medical Reports Fourth Quarter and Full Year 2025 ResultsAUDUBON, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025: Worldwide net sales were $826.4 million, an increase of 25.7%, or an increase of 24.7% on a constant currency basis.Base business, excluding Nevro, net sales were $726.7 million, an increase of 10.6%, or an increase of 9.4% on a constant currency basis.GAAP net income for the quarter was $140.6 million.GAAP diluted earnings per share ("EPS") was $1.03, an increase of 442.6%. Non-GAAP diluted EPS was $1.28, an increase of 52.1%. Full Year
- INSIDEREVP, GC, Corporate Secretary Huller Kelly exercised 10,000 shares at a strike of $45.64 and sold $876,700 worth of shares (10,000 units at $87.67) (SEC Form 4)4 - GLOBUS MEDICAL INC (0001237831) (Issuer)
- PRGlobus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference CallAUDUBON, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full-year ended December 31, 2025 after the market close on Tuesday, February 24, 2026. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com. Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Participants may access the conference call live via webcast on the Investors page of Globus Medical's website at https://www.investors.globusmedical.com/news-
- ANALYSTGlobus Medical upgraded by Needham with a new price targetNeedham upgraded Globus Medical from Hold to Buy and set a new price target of $112.00
- ANALYSTTD Cowen initiated coverage on Globus Medical with a new price targetTD Cowen initiated coverage of Globus Medical with a rating of Buy and set a new price target of $110.00
- INSIDERSEC Form 4 filed by Director Norwalk Leslie V4 - GLOBUS MEDICAL INC (0001237831) (Issuer)
- INSIDERSEC Form 4 filed by President, CEO Pfeil Keith W4 - GLOBUS MEDICAL INC (0001237831) (Issuer)
- INSIDERSEC Form 4 filed by Senior Vice President, CFO Kline Kyle4 - GLOBUS MEDICAL INC (0001237831) (Issuer)
- INSIDERSEC Form 4 filed by Executive Chairman Paul David C4 - GLOBUS MEDICAL INC (0001237831) (Issuer)
- INSIDERSEC Form 4 filed by Director Douglas Robert Andrew4 - GLOBUS MEDICAL INC (0001237831) (Issuer)
- INSIDERSEC Form 4 filed by Director Lemaitre Dan4 - GLOBUS MEDICAL INC (0001237831) (Issuer)
GMED FAQ
7 questionsWhat does Globus Medical Inc. do?
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Its offers spine products, such as consists of traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies, such as dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral...Where does GMED stock trade?
Globus Medical Inc. (GMED) is listed on NYSE.What sector and industry is GMED in?
Globus Medical Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Globus Medical Inc. go public?
Globus Medical Inc. (GMED) completed its IPO in 2012.What are analysts saying about GMED?
Globus Medical Inc. has had 8 recent analyst actions on file. The most recent action was from Needham: Buy on 2026-01-30.What companies are similar to GMED?
Notable peers in the same industry include NUVA (NuVasive Inc.), ATEC (Alphatec Holdings Inc.), SPNE (SeaSpine Holdings Corporation). Compare GMED side-by-side with any of them on Quantisnow.How can I track GMED on Quantisnow?
Quantisnow aggregates Globus Medical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow GMED to receive live email and push alerts on every new disclosure.